United States · Bill · HR
H.R. 2064 (116th)
To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.
Introduced
3 April 2019
Last action
—
Status
Subcommittee Hearings Held.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
This bill requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 3 April 2019
Introduced in House (PDF)
Introduced in House · EN · 3 April 2019
Introduced in House
summary · EN · 3 April 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/2064
- Open data entity: https://api.congress.gov/v3/bill/116/hr/2064